2.04
+2.00%
Close of 9 Nov 2026, in EUR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Biotalys
Its shares trade on Euronext Brussels under the ticker BTLS.BR. It has been listed since 2 July 2021.
Biotalys NV engages in the development of sustainable crop protection products. The company is headquartered in Ghent, Oost-Vlaanderen. The company went IPO on 2021-07-02. AGROBODY Foundry is a product of this company that provides crop protection products, based on active ingredients in combination with Agrobodies as formulation agents. The company develops technology for sustainable crop protection. The company offers tools to prevent crop loss while extending post-harvest protection and reducing food waste. This company provides protein-based biocontrol solutions. Biotalys allows biocontrol solutions to tackle a wide range of crop pests and diseases. This company has built a product pipeline against key pests and diseases known as EvocaTM. The company also has a range of products pipeline of BioFungicides, BioInsecticides and BioBactericides.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Materials
- Industry
- Chemicals
- Listed since
- 2 Jul 2021
- Employees
- 74
- Website
- biotalys.com ↗
Leadership
Pay as last reported
- Dr. Simon MoroneyIndependent Non-Executive Chairman of the Board€60,094
- Mr. Kevin HelashChief Executive Officer, Director, since 2023
- Mr. Douglas MinderChief Financial Officer
- Mr. Luc MaertensChief Operating Officer
- Dr. Carlo BouttonChief Scientific Officer
- Mr. Kamal El MernissiChief Business Development Officer
- Mr. Patrick McdonnellChief Business Officer
- Ms. Laura MeyerDirector
- Mr. Piet BevernageNon-Executive Director
- Dhr. Patrick Van BenedenNon-Executive Director, since 2020
- Dr. Johan CardoenIndependent Director
- Dr. Michiel Van Lookeren CampagneIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Biotalys NV develops sustainable crop protection products like AGROBODY Foundry with Agrobodies as formulation agents.
- Biotalys NV has a product pipeline including EvocaTM against key pests and diseases.
- Biotalys NV offers protein-based biocontrol solutions for tackling crop pests and diseases.
Weaknesses
- Biotalys NV has only 74 employees which may limit its operational capacity.
- Biotalys NV's IPO on 2 July 2021 may indicate limited market traction.
- Biotalys NV's focus on chemicals in the Materials sector may face regulatory challenges.
Opportunities
- Biotalys NV can expand its product pipeline in BioFungicides, BioInsecticides, and BioBactericides.
- Biotalys NV can leverage its protein-based biocontrol solutions to reduce food waste.
- Biotalys NV can target the growing demand for sustainable crop protection in the Chemicals industry.
Threats
- Biotalys NV faces competition from established players in the Chemicals sector.
- Biotalys NV's reliance on a single product line AGROBODY Foundry may pose risks.
- Biotalys NV's operations in Ghent, Belgium may be affected by regional economic fluctuations.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.